Literature DB >> 3940742

Interstitial pneumonitis in autoimmune MRL/lpr mice and its treatment with cyclosporin A.

H Okudaira, T Ogita, T Miyamoto, J Shiga, M Suko, K Okudaira, E Terada, A Ghoda, K Terada, M Saito.   

Abstract

Age-associated changes of anti-double-stranded (ds) DNA antibodies, anti-single-stranded (ss) DNA antibodies, and serum immune complex concentrations were studied in MRL/lpr mice. All anti-ds DNA antibodies, anti-ss DNA antibodies, and immune complexes began to be detected in the sera of MRL/lpr mice aged 8 to 13 weeks and increased remarkably after 17 weeks of age. Almost no pathological findings were observed histologically in the lungs of MRL/lpr mice aged 8 weeks but interstitial pneumonitis became evident at 14 weeks of age. Peribronchial and perivascular lymphocyte infiltrations were seen in the lungs of 14-week-old MRL/lpr mice and became more severe at 21 weeks of age. Oral administration of cyclosporin A to 15-week-old MRL/lpr mice markedly prolonged their life span. The lungs of 44-week-old MRL/lpr mice given cyclosporin A showed few pathological findings except for minimal perivascular lymphocyte infiltration.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3940742     DOI: 10.1016/0090-1229(86)90121-2

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  3 in total

1.  Therapeutic effect of 15-deoxyspergualin on the progression of lupus nephritis in MRL mice. I. Immunopathological analyses.

Authors:  S Ito; M Ueno; M Arakawa; T Saito; T Aoyagi; M Fujiwara
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

2.  Experimental treatment of autoimmune MRL-lpr/lpr mice with immunosuppressive compound FK506.

Authors:  K Yamamoto; A Mori; T Nakahama; M Ito; H Okudaira; T Miyamoto
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

3.  Inhibition of in vitro NZB antibody responses by cyclosporine.

Authors:  D S Pisetsky
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.